Computer science, Artificial Intelligence, Cyclist, Senior Vice President, Head of Global Product Innovation Clinical Ink
Iowa City, IA
Joined February 2007
- Tweets4.3K
- Following380
- Followers401
- Likes2.7K
Steve Polyak retweeted
Independence Day is a reminder that America is not the project of any one person. The single most powerful word in our democracy is the word ‘We.’ ‘We The People.’ ‘We Shall Overcome.’ ‘Yes We Can.’ America is owned by no one. It belongs to all citizens. And at this moment in history—when core democratic principles seem to be continuously under attack, when too many people around the world have become cynical and disengaged—now is precisely the time to ask ourselves tough questions about how we can build our democracies and make them work in meaningful and practical ways for ordinary people.
Steve Polyak retweeted
Motivated by financial troubles, Dickens wrote “A Christmas Carol” during his nighttime walks around London.
Next time you’re struggling with bills, may we recommend a quick jaunt around the 1840’s Kent countryside?
Steve Polyak retweeted
"If we want to truly equip our students to understand and navigate the political environment that exists today, we have to think about how we teach the discipline of history more broadly."
edsurge.com/news/2023-10-11-…
Steve Polyak retweeted
The FDA is recognizing the power of CGM tech in diabetes clinical trials. Real-time data is vital for patients, understanding glycemic excursions & contextual hyperglycemia insights.
info2.clinicalink.com/social…
#CGM #diabetes #hypoglycemia #glucose #FDA #clinicaltrials
Steve Polyak retweeted
Not sure how you can look at this data, ostensibly be interested in either meritocracy or equality, and want to move away from standardized tests. It's the subjective measures that are most slanted in favor of the rich kids.
nytimes.com/interactive/2023…
Steve Polyak retweeted
Megan Rapinoe. The All-American Hero. She’s chasing a historic three-peat championship and another star for the @uswnt for her last trip to the big stage. @mpinoe 🦅🇺🇸
#JustDoIt #NikeFootball
Steve Polyak retweeted
Hear from clinical experts about the advancement of diabetes clinical trials and the integration of patient-centered technology. Access the on-demand recording now.
info2.clinicalink.com/social…
#DiabetesResearch #ClinicalTrials #PatientCentered #Technology #CGM
Steve Polyak retweeted
Soura Dasgupta, a @uiowaengr professor, has received a $3.2 million @NIH grant to improve detection and treatment of Parkinson’s disease. spr.ly/6011PyNA5
ALT Iowa Engineering professor Soura Dasgupta in a light blue shirt, standing in front of a wall of windows with his arms crossed in front of him
Steve Polyak retweeted
We are excited to welcome our new Chief Technology Officer, Andrew F Kraus! Andrew brings 30 years of expertise and leadership in developing clinical technologies.
Read announcement: info2.clinicalink.com/social…
#CTO #Innovation #Leadership #ClinicalTechnology
Steve Polyak retweeted
How are digital health technologies transforming clinical trials? Discover how our team at Clinical ink is engineering a robust analytics platform to enable precise, objective, and frequent monitoring of patients.
info2.clinicalink.com/social…
#Sensors #Wearables
Steve Polyak retweeted
Very pleased to share our latest work. Digital technology coupled with clinical testing has given us a better understanding on progression in a de novo PD group. @MaxBrzezicki @HarrisSotirakis @NI_Oxford @ucb_news and Niall @NDCNOxford @OxNeuro cell.com/heliyon/fulltext/S2…
New report from @MaxBrzezicki @NeuroMetrology & @NDCNOxford colleagues finds #Parkinsons progression in de novo PD patients can be measured by digitally-measured movement-related biomarkers, but this is obscured by commencement of symptomatic medication
cell.com/heliyon/fulltext/S2…
Steve Polyak retweeted
Eng team 1: “We do what product or the business folks tells us to do. Not our job to decide what we work on!”
Eng team 2: “We work with product and the business folks to help decide what to do. Our job includes making sure we work on the right thing for the business.”
Steve Polyak retweeted
De-risking patient participation by developing clinical trial solutions around the patient experience is critical. Hear Joan Severson, our CIO, and experts on The Real Chemistry podcast. Contact us to learn how our technology improves your trial success.
info2.clinicalink.com/social…
Steve Polyak retweeted
Analyzing the dataset from the Watch-PD study to determine if digital biomarkers can accurately assess symptomatic treatment response in Parkinson's Disease and predict disease progression in ALS. Get the details in free White Paper.
info2.clinicalink.com/social…
#DigitalBiomarkers
